logo.gif
BGHL (EUR): NAV(s)
March 19, 2024 02:30 ET | BOUSSARD AND GAVAUDAN HOLDING LIMITED (EUR)
                                      BOUSSARD & GAVAUDAN HOLDING LIMITED Ordinary Shares The Directors of Boussard & Gavaudan Holding Limited would like to announce the following...
logo.gif
BGHL (GBP): NAV(s)
March 19, 2024 02:30 ET | BOUSSARD AND GAVAUDAN HOLDING LIMITED (GBP)
                                      BOUSSARD & GAVAUDAN HOLDING LIMITED Ordinary Shares The Directors of Boussard & Gavaudan Holding Limited would like to announce the following...
Obseva Logo highresolution.jpg
ObsEva Announces Update on Board of Directors
March 19, 2024 02:00 ET | ObsEva SA
Ad hoc announcement pursuant to Art. 53 LR of the SIX Swiss Exchange GENEVA, Switzerland – March 18, 2024 – ObsEva SA (SIX: OBSN), a biopharmaceutical company developing and commercializing novel...
evolverd_1200x628.jpg
Stephen Samuel Transforms Industries: From Premier Pharmacy Services to Evolve Realty & Development Corp.
March 18, 2024 17:27 ET | Evolve Realty & Development
BEVERLY HILLS, CA, March 18, 2024 (GLOBE NEWSWIRE) -- In a dynamic business world where adaptability and vision are the keys to lasting success, Stephen Samuel stands out as a transformative figure....
Inventiva announces
Inventiva announces positive results from the Phase II, LEGEND, Proof-of-Concept study combining lanifibranor with empagliflozin in patients with MASH/NASH and T2D
March 18, 2024 16:00 ET | INVENTIVA
LEGEND achieved its primary efficacy endpoint by significantly lowering HbA1c level in both the lanifibranor arm and in the lanifibranor with empagliflozin arm compared to placebo.Statistical...
Inventiva annonce le
Inventiva annonce les résultats positifs de l’essai clinique de Phase II, preuve de concept, LEGEND, combinant lanifibranor et empagliflozine chez des patients atteints de MASH/NASH et de diabète de type 2
March 18, 2024 16:00 ET | INVENTIVA
LEGEND a atteint son critère principal d’efficacité en réduisant de manière significative le taux d’hémoglobine HbA1c dans les groupes recevant lanifibranor seul ou en combinaison avec empagliflozine,...
FL_noir-blanc2.jpg
FL Entertainment: weekly share transactions
March 18, 2024 14:30 ET | FL Entertainment
Press Release Paris – 18 March 2024 Share Transactions Disclosure FL Entertainment N.V. (894500G73K46H93RF180) declares the following transactions made on its own shares (NL0015000X07) from 11...
Transaction in Own Shares
March 18, 2024 14:06 ET | Shell plc
Transaction in Own Shares 18 March, 2024 • • • • • • • • • • • • • • • • Shell plc (the ‘Company’) announces that on 18 March 2024 it purchased the following number of Shares for cancellation. ...
Director/PDMR Shareholding
March 18, 2024 13:18 ET | Shell plc
NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES IN ACCORDANCE WITH THE REQUIREMENTS OF THE EU AND UK MARKET ABUSE REGIMES March 18, 2024 1....
logo.png
Volta Finance Limited - Net Asset Value as at 29 February 2024
March 18, 2024 13:15 ET | Volta Finance Limited
Volta Finance Limited (VTA / VTAS) – February 2024 monthly report NOT FOR RELEASE, DISTRIBUTION, OR PUBLICATION, IN WHOLE OR PART, IN OR INTO THE UNITED STATES ***** Guernsey, March 18th,...